Aidan Murphy, Ph.D. - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Newsroom  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Contacts

    • Subscribe
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Locations
    • Adverse Event Reporting
    • Subscribe
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Health
      < Back
    • Health
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
    • R&D
    • Pipeline
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Partnering
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership Team
  4. leadership

Aidan Murphy, Ph.D.

Post navigation

Previous
Next
Aidan Murphy, Ph.D.

Aidan Murphy, Ph.D.

  • Executive Vice President,
  • Technical Operations
  • Follow in LinkedIn

Aidan Murphy, Ph.D. was appointed Executive Vice President, Technical Operations in January 2018.

Aidan has more than 25 years’ experience in the pharmaceutical and biotechnology industry, and since joining Ipsen in 2006 has held several manufacturing leadership roles across the globe.

Prior to his current role, Aidan was Senior Vice President, Biologics Development and Manufacturing, and has also led Ipsen’s manufacturing sites in Tianjin (China), Dublin (Ireland), and Wrexham (UK) and occupied global roles as SVP CMC (Chemistry, Manufacturing, and Controls) Development & Engineering and Head of Specialty Care Manufacturing. He holds a Ph.D. in organic chemistry from Trinity College, Dublin.

Related stories

Ipsen’s partnership with Marengo
02 June 2023 0 mins read

Ipsen’s partnership with Marengo

Diana: Taking spasticity in stride   
31 May 2023 1 mins read

Diana: Taking spasticity in stride   

Related assets

Ipsen sites – Wrexham, UK

Ipsen sites – Wrexham, UK

Ipsen sites – Wrexham, UK

Ipsen sites – Wrexham, UK

Ipsen sites – Milton Park, UK

Ipsen sites – Milton Park, UK

IPN price

€103.50

 €1.30 (1.27%)

  • Media Library
  • Adverse Event Reporting
  • Annual Report
  • Locations
  • Contacts

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Contacts
  • Terms & Conditions
  • Cookie Policy
  • Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
♿
Increase the text(+) Decrease the text(-) Reset
Screen Reader
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.